Novartis Announces Exploratory Analysis To Be Presented During ASCO 2020 Demonstrating Kisqali Shows 'Overall Survival Benefit In Hr+/Her2- Advanced Breast Cancer With Consistent Findings In Patients With More Aggressive Disease'
Benzinga Newsdesk